HIV Survival Benefit Associated with Earlier Antiviral Therapy [2] (multiple letters)

Annals of Internal Medicine

Volumn 140, Issue 7, 2004, Pages 578-579

  Mocroft, Amanda ^a   Phillips, Andrew N ^a   Lundgren, Jens D ^b   Palella Jr , Frank J ^c   Chmiel, Joan S ^c   Holmberg, Scott D ^d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HVIDOVRE HOSPITAL   (Denmark)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

DISEASE ACTIVITY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURVIVAL; T LYMPHOCYTE; TOXICITY; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS LOAD;

EID: 1842435113     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-7-200404060-00024     Document Type: Letter

References (0)